Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04400435 · ClinicalTrials.gov registry record
Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 1,258
- Enrollment target
NCT04400435 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 1,258 participants.
The verdict
NCT04400435 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 1,258 participants
- Enrollment target
Study Summary
The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
Interventions
- DEVICE Use of Eko DUO electronic stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,258 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2022-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04400435
The ClinicalTrials.gov registry entry for NCT04400435 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eko Devices, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko DUO electronic stethoscope is the first listed.
NCT04400435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04400435 about?
NCT04400435 is a clinical study titled "Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence". The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
What is the current status of trial NCT04400435?
This trial is currently completed. The enrollment target is 1,258 participants. The study started on 2020-07-15. Estimated completion is 2022-04-29.
What interventions are being tested in trial NCT04400435?
The interventions under investigation include: Use of Eko DUO electronic stethoscope (DEVICE).
Who is sponsoring clinical trial NCT04400435?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.